Dan Broderick is Vice President, Capital Formation and Entrepreneurship at BioSTL – the parent corporation BioGenerator, which is the lead pre-seed stage investor in Apse. Dan has over 22 years of experience in the life sciences and venture capital industry. Prior to joining Prolog Ventures in 2007, Dan spent 7 years with Mason Wells Biomedical Fund as a Managing Director where he was responsible for all aspects of investment activities. Prior to Mason Wells, Dan spent 18 years at Mayo Clinic in Rochester, Minnesota, where for 12 years he served as Director of the Office of Technology Commercialization. Dan has served on numerous Boards of Directors including The National Venture Capital Association. Dan received a Bachelors Degree in Biology from Iowa State University in 1982.